Global Spine Biologics Market Forecast 2016-2026

LONDON, November 30, 2016 /PRNewswire/ --

Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers 

The global Spine Biologics market is expected to grow at a moderate single digit growth rate over the forecast period. The global spine biologics market was valued at $2,997m in 2015. Visiongain forecasts this market to increase to $3,899m in 2020. The market will then continue to increase to $5,604m in 2026, growing at a CAGR 6.2% between 2020 and 2026.

How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 142-page report you will receive 125 in-depth charts - all unavailable elsewhere.

The 142 page report provides clear detailed insight into the global spine biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Report Scope
• Global Spine Biologics market forecasts from 2016-2026

• Spine biologics national market forecasts from 2016-2026, covering:
- United States
- Canada
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Rest of Europe
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- Rest of the World

• Spine Biologics submarket forecasts from 2016-2026 covering:

- Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by product:
• Demineralized Bone Matrix
• BMP/Growth Factor
• Bone Substitutes
• Cell Based Matrices
• Machined Bone
• Allograft Bone
• Platelet Concentrators

- Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by type of surgery:
• Traditional Fusion
• Interbody Fusion

- Revenue forecasts to 2026 are provided for the following segments in the spine biologics market, by end user:
• Inpatient Surgery Centers
• Outpatient Surgery Centers

• Analysis of the key factors driving growth in the global, regional and country level of spine biologics market from 2016-2026

• Assesses selected leading companies, examining recent performance and outlooks.

• Assessment of leading companies in the spine biologics market as well as strengths, weaknesses, opportunities, and threats in the market.

Visiongain's study is intended for anyone requiring commercial analyses for the Spine Biologics Market and leading companies. You find data, trends and predictions.

Buy our report today Global Spine Biologics Market Forecast 2016-2026: Demineralized Bone Matrix, BMP/Growth Factor, Bone Substitutes, Cell Based Matrices, Machined Bone, Allograft Bone, Platelet Concentrators, Traditional Fusion, Interbody Fusion, Inpatient and Outpatient Surgery Centers.

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1752/Global-Spine-Biologics-Market-Forecast-2016-2026

List of Companies and Organisations Mentioned 

Alphatec Holdings, Inc..

Biomet, Inc.

CelgenTek Innovations Corporation

Chinese Academy of Sciences

Covidein plc

DePuy Synthes

EMA

FDA

Globus Medical, Inc.

Indo UK Institute of Health (IUIH)

Integra LifeSciences Holdings Corporation

Japanese Health Ministry

Johnson & Johnson

LifeNet Health

Medtronic plc

Mega Surgical

NuVasive, Inc.

Orthovita Inc.

Osiris Therapeutics, Inc.

SeaSpineHoldings, Inc.

Stryker Corporation

Therapure Biopharma

Transplant Technologies of Texas, Ltd.

Weizmann Institute of Science

Zimmer Biomet Holdings, Inc.

Zimmer, Inc.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd